Enterococcus faecalis can live in the intestine without causing illness. A high GI-MAP stool result measures a species DNA target above the laboratory’s range; it is not equivalent to finding this bacterium in a blood or urine specimen collected to investigate an infection.
On this page
How E. faecalis relates to Enterococcus
E. faecalis is one species within the Enterococcus genus. It is distinct from E. faecium. Human studies have found both species in intestinal samples, including in people outside hospital settings. Finding the species is not, by itself, evidence of invasive disease. [1]
What GI-MAP reports
GI-MAP provides a species-targeted DNA result. A high flag means the measured amount exceeds the laboratory’s range for that assay; it does not directly demonstrate tissue invasion or an inflammatory response. A species name also does not identify the strain’s full genetic or antibiotic-resistance profile. [2]
What the finding cannot diagnose
It cannot establish a urinary tract infection, heart-valve infection or bloodstream infection. Those concerns require assessment of symptoms and the relevant body site. It also cannot explain abdominal symptoms solely because the value is high.
If the genus and E. faecalis lines differ, do not assume the report is inconsistent or add the figures together. The targets and reporting rules can differ. Ask the laboratory about overlap if that comparison matters to interpretation.
Colonization, infection and resistance answer different questions
Colonization means an organism is present without causing an infection. Infection involves illness assessed in its clinical setting. Resistance describes whether an organism can withstand a particular antibiotic. A species name or an unusually high stool quantity cannot establish all three.
CDC notes that enterococci normally occur in the intestine and that even vancomycin-resistant enterococcal colonization does not require antibiotics. This does not mean a suspected infection should be ignored: when infection is present, the specimen and susceptibility results help a clinician choose treatment. [3]
Three common report situations
- High stool value, no new illness: discuss why the test was ordered and whether the finding changes a care decision. The number alone is not an eradication target.
- High stool value and burning or frequent urination: explain the urinary symptoms to your clinician. A stool result does not replace evaluation of the urinary tract.
- Fever or feeling seriously unwell: seek prompt clinical assessment. Do not wait for a repeat gut panel to decide whether an infection elsewhere needs investigation.
A report can list Enterococcus spp., E. faecalis and E. faecium on separate lines. These are not three unrelated organisms to add together: one is a broader group and two are named species. Assay targets can overlap, and the laboratory can explain its reporting rules.
Before a repeat test, agree on the question it is meant to answer. Symptom improvement, confirmation of a clinically suspected infection and a change in stool DNA quantity are different outcomes. Recording the treatment history and collection date makes the comparison more useful.
Common questions
Does this mean I have vancomycin-resistant Enterococcus?
No. The species quantity does not establish vancomycin resistance. That requires appropriate resistance or susceptibility evidence.
Should high E. faecalis be eradicated from the gut?
A flag alone is not an indication for eradication. A clinician should identify whether there is an actual infection or another reason to intervene.
Is Enterococcus faecalis the same as E. coli?
No. Enterococcus faecalis and Escherichia coli are different bacterial species. Use the full name and specimen type when discussing a laboratory report.
Can GI-MAP choose an antibiotic for E. faecalis?
The species quantity does not provide a complete antibiotic susceptibility result. Treatment decisions for an infection need clinical assessment and appropriate laboratory evidence; a stool flag alone is insufficient.
Sources and review
Sources checked November 1, 2026. Manufacturer material describes the test; clinical guidance and research support the interpretation limits.
- Population biology of intestinal Enterococcus isolates, 2015
- Diagnostic Solutions Laboratory: GI-MAP interpretive guide (manufacturer specifications)
- CDC: Vancomycin-resistant enterococci, colonization and infection
This article, including the November 1 update, has been reviewed by Madison Ordway, FDN-P. For a correction or source question, contact Gi Map Test.